Zealand Pharma A/S (ZEAL): Price and Financial Metrics

Zealand Pharma A/S (ZEAL)

Today's Latest Price: $37.63 USD

1.33 (3.66%)

Updated Nov 27 10:11am

Add ZEAL to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

ZEAL Stock Summary

  • Of note is the ratio of Zealand Pharma A's sales and general administrative expense to its total operating expenses; merely 0.45% of US stocks have a lower such ratio.
  • For ZEAL, its debt to operating expenses ratio is greater than that reported by merely 0.52% of US equities we're observing.
  • With a year-over-year growth in debt of -100%, Zealand Pharma A's debt growth rate surpasses only 0% of about US stocks.
  • Stocks that are quantitatively similar to ZEAL, based on their financial statements, market capitalization, and price volatility, are CPE, XEC, FANG, GTE, and BTU.
  • ZEAL's SEC filings can be seen here. And to visit Zealand Pharma A's official web site, go to www.zealandpharma.com.

ZEAL Stock Price Chart Interactive Chart >

Price chart for ZEAL

ZEAL Price/Volume Stats

Current price $37.63 52-week high $44.60
Prev. close $36.30 52-week low $22.00
Day low $37.21 Volume 4,053
Day high $37.82 Avg. volume 6,781
50-day MA $37.77 Dividend yield N/A
200-day MA $36.01 Market Cap 1.50B

Zealand Pharma A/S (ZEAL) Company Bio

Zealand Pharma A/S, a biotech company, engages in the discovery, design, and development of novel peptide-based medicines in Denmark. The company was founded in 1997 and is based in Copenhagen, Denmark.

ZEAL Latest News Stream

Event/Time News Detail
Loading, please wait...

ZEAL Latest Social Stream

Loading social stream, please wait...

View Full ZEAL Social Stream

Latest ZEAL News From Around the Web

Below are the latest news stories about Zealand Pharma A that investors may wish to consider to help them evaluate ZEAL as an investment opportunity.

Zealand Pharma A/S (ZEAL) Investor Presentation - Slideshow

The following slide deck was published by Zealand Pharma A/S in conjunction with this event....

SA Transcripts on Seeking Alpha | September 14, 2020

Zealand Pharma A/S (ZEAL) CEO Emmanuel Dulac on Q2 2020 Results - Earnings Call Transcript

Zealand Pharma A/S (ZEAL) Q2 2020 Results Conference Call August 13, 2020 10:00 AM ET Company Participants Mads Kronborg - Head of Investor Relations and Communication Emmanuel Dulac - President and Chief Executive Officer Matt Dallas - SVP and Chief Financial Officer Adam Steensberg - EVP, Research & Development and...

SA Transcripts on Seeking Alpha | August 14, 2020

Zealand Pharma Expands U.S. Operations, Opens New Boston Office

·Commercial operations will be headquartered in Boston, as company looks to commercialize pipeline in the U.S. Copenhagen, DK and Boston, MA, U.S. July 6, 2020 – Zealand Pharma A/S (ZEAL.CO) (CVR-no. 20045078,) a biotechnology company changing lives with innovative peptide-based medicines, today announced the opening of its new U.S. headquarters in Boston which will be led by recently appointed President of Zealand Pharma U.S., Frank Sanders.

Yahoo | July 6, 2020

Zealand (ZEAL) Surges: Stock Moves 9.1% Higher

Zealand (ZEAL) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.

Yahoo | July 2, 2020

Total number of shares and voting rights in Zealand Pharma at June 30, 2020

Zealand Pharma A/S (“Zealand”) (ZEAL.CO) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, in accordance with Section 10 of the Danish Statutory Order on Issuers' Disclosure Obligations, announces the total number of shares and voting rights in the Company at the end of a calendar month during which there have been changes to its share capital. In Company announcement No. 32/2020 from June 12, 2020, Zealand announced an increase in share capital relating to the exercise of employee warrants, and in Company announcement No. 36/2020 from June 22, 2020, Zealand announced an increase in share capital relating to the completion of a private placement and directed issue of new shares.

Yahoo | June 30, 2020

Read More 'ZEAL' Stories Here

ZEAL Price Returns

1-mo 14.76%
3-mo -0.79%
6-mo -8.22%
1-year 21.35%
3-year 179.78%
5-year N/A
YTD 13.34%
2019 185.96%
2018 -14.63%
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7789 seconds.